Cybin CEO Doug Drysdale talks to Jason Najum about treating mental health disorders with psychedelics and attracting new buyers with its stock price.

The U.S. Food and Drug Administration (FDA) has issued a complete response letter for MDMA-assisted psychotherapy (MDMA-AT) ...

Add a description, image, and links to the molecule-driver topic page so that developers can more easily learn about it.

Attendees are allowed one “communal gift” per week: A choice of up to 2 grams of a psilocybin mushroom blend, a set of seven psilocybin microdoses, or a 10mg dose of DMT. (Olivia Sun, The Colorado Sun ...

Research is ongoing — and most hallucinogenic drugs remain illegal in the United States — but we’re beginning to understand their possible role in mental health care. Recent studies suggest ...

Cumulus Oncology Ltd. is in the thick of raising a $50 million series A round as its model of sourcing novel drug targets emerging from academia, shaping them up for clinical development, and spinning ...

The pilot that intentionally 'tried to crash a plane' with 83 passengers onboard while under the influence has revealed his side of events. Joseph David Emerson is awaiting trial after being ...

Research is ongoing about the effectiveness of using psychedelics such as psilocybin and how they compare to more traditional treatment options. Evidence from a recent review suggests that the ...

The new regulations establish Colorado’s psychedelics industry by growing mushrooms, operating a therapy center, or manufacturing psilocybin edibles now with guidance on how to do all of the ...

Click to expand... I agree that LSD & psilocybin don't belong on the Schedule I list, though unrelated to their medical use - they do not meet their own definition of addictive drugs & should ...